Flexprint substrate enzyme sensor for determination of daily glucose-profiles for diabetic patients

The goal is to develop a miniaturized system allowing continuous measurement of glucose concentration profiles over 24 hours for several days. The unique feature of the PharmaSens / IMT approach lies in the insertion mechanism and the needle size to assure optimum user-friendliness and patient comfort. The measurement method is based on classical amperometric detection using an enzymatic membrane. The sensor substrate is made on a flexprint substrate and consists of a 3-electrode cell on a needle-shaped tip of  100 μm width and is covered with polymeric membranes. The sensor is integrated in a device that combines the insertion mechanism and electronics.


    • EPFL-POSTER-165810

    Record created on 2011-05-16, modified on 2016-08-09


  • There is no available fulltext. Please contact the lab or the authors.

Related material